8IQS image
Entry Detail
PDB ID:
8IQS
Keywords:
Title:
Crystal structure of Anti-PEG antibody M11 Fv-clasp fragment with PEG (co-crystallization with PEG3350)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2023-03-17
Release Date:
2024-03-20
Method Details:
Experimental Method:
Resolution:
2.16 Å
R-Value Free:
0.27
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:M11 VH-SARAH
Chain IDs:B (auth: H), D (auth: h)
Chain Length:188
Number of Molecules:2
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:M11 VL-SARAH
Chain IDs:A (auth: L), C (auth: l)
Chain Length:179
Number of Molecules:2
Biological Source:Mus musculus
Primary Citation
The strategy used by naive anti-PEG antibodies to capture flexible and featureless PEG chains.
J Control Release 380 396 403 (2025)
PMID: 39921032 DOI: 10.1016/j.jconrel.2025.02.001

Abstact

Polyethylene glycol (PEG) is widely used as a standard stealth polymer, although the induction of anti-PEG antibodies and consequent effects have drawn attention in recent years. To date, several anti-PEG antibodies induced by PEG-modified proteins via the T cell-dependent (TD) pathway, in which affinity maturation occurs, have been reported. In contrast, structures of the naïve anti-PEG antibodies before affinity maturation have not been described in the literature. Here, to understand the details of the naïve anti-PEG antibodies capturing PEG, we studied a naïve anti-PEG antibody induced by a PEG-modified liposome in the absence of affinity maturation via the T cell-independent (TI) pathway. The mutation levels, structures as well as in vitro and in silico binding properties of TI and TD anti-PEG antibodies were compared. The TI anti-PEG antibody showed no mutation and a low binding affinity toward PEG, meanwhile, it allowed PEG chain sliding and weak interaction with the terminal group. Furthermore, the naïve anti-PEG antibodies may obtain high affinities by forming tunnel structures via minimal mutations. This research provides new insights into polymer-antibody interactions, which can facilitate the development of novel stealth polymers that can avoid antibody induction.

Legend

Protein

Chemical

Disease

Primary Citation of related structures